QQ客服 官方微博 反馈留言

	Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resistance to IMiDs in Multiple Myeloma
	Liu, Jiye; Zhou, Wenrong; Xing, Lijie; Lin, Liang; Wen, Kenneth; Tai, Yu-Tzu; Hideshima, Teru; Cang, Yong; Anderson, Kenneth C.
	2018
会议名称	60th Annual Meeting of the American-Society-of-Hematology (ASH)
会议日期	DEC 01-04, 2018
卷号	132
DOI	10.1182/blood-2018-99-111962
收录类别	CPCI-S ; SCIE
会议录	BLOOD
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/6027652
专题	山东大学
作者单位	1.Harvard Med Sch, LeBow Inst Myeloma Therapeut, Boston, MA USA. 2.[Liu, Jiye 3.Xing, Lijie 4.Lin, Lia
推荐引用方式 GB/T 7714	Liu, Jiye,Zhou, Wenrong,Xing, Lijie,et al. Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resistance to IMiDs in Multiple Myeloma[C]. 见:60th Annual Meeting of the American-Society-of-Hematology (ASH). DEC 01-04, 2018.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。